MYC and plasma cell myeloma: We exposed SKO and RPMI multiple myeloma cells and BC3 and BCBL1 PEL cells to c-Myc inhibitor (I c-Myc) as their cell growth is known to be dependent on c-Myc overexpression [3,4].